Evaluation of the impact of a disease specific informational meeting on disease related knowledge, health conditions and disease perception of patients with systemic lupus erythematosus (SLE) and granulomatosis with polyangiitis (GPA)

Not Applicable

• Conditions: M32.9; M31.3; Systemic lupus erythematosus, unspecified; Wegener granulomatosis

• Registration Number: DRKS00016603
• Lead Sponsor: niversitätsklinikum Halle (Saale)Klinik für Innere Medizin II

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-10-10
• Study Completion: 2020-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 117

Inclusion Criteria

Valid diagnosis of
1.) systemic lupus erythematosus or
2.) granulomatosis with polyangiitis

- Adult patients of at least 18 years

-Fluent understandig of German language

- Willingness to takt part in the informational meeting and the survey

Exclusion Criteria

- High disease activity or comorbid condition that prevents the patient from being capable to take part in the intervention

- Severe reduction of intelligence that renders the perception of information impossible.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
disease knowledge

Secondary Outcome Measures

Name	Time	Method
perception of disease,<br>health condition